Abstract:With the recent success of immunotherapy targeting immune checkpoints, interest in understanding the function of immune checkpoint modulators such as the B7 family proteins escalated. B7-H3 is a transmembrane glycoprotein and a member of the B7 family of immunoregulatory proteins. Extensive studies have shown that B7-H3 is important in regulating the activity of immune cells. We are among the first groups to show that in addition to immunoregulatory function, B7-H3 also has non-immunological functions, which may contribute to its role in tumor progression. Overexpression of B7-H3 is associated with tumor progression and poor patient outcome in multiple types of cancers. However, studies on how B7-H3 regulates cancer growth and metastasis are rare and the mechanisms underlying the role of B7-H3 in cancer malignancy are almost unknown. We and others have shown that B7-H3 mediates breast cancer invasion, metastasis and drug resistance and that silencing B7-H3 delays tumor growth and sensitizes cancer cells to chemotherapeutic agents in immune-independent in vitro and in vivo assays, indicating immunoregulatory B7-H3 also has immune-independent function. In this study, we investigated the role of B7-H3 in cancer cell metabolic reprograming in vitro and in two independent xenograft mouse models. We found that B7-H3 increased glucose uptake and lactate production while it suppressed oxygen consumption in B7-H3 high-expressing cells, indicating that B7-H3 promotes Warburg effect. B7-H3 increased the protein levels of HIF-1α and its downstream targets LDHA and PDK1, which are key enzymes in glycolytic metabolism. Moreover, B7-H3 promotes HIF-1α stability via enhanced reactive oxygen species (ROS) by suppressing the activity of transcription factor Nrf2 and mitochondrial Nrf2 target genes, including antioxidant enzymes SOD1, SOD2 and PRX3. B7-H3 mediated HIF-1α stability is suppressed by ROS scavenger treatment including N-acetylcysteine and PEG-catalase. Metabolic imaging of human breast cancer xenograft in mice further demonstrated that B7-H3 enhances tumor glucose uptake and tumor growth. Together, our results show that B7-H3 regulates cancer glucose metabolism via ROS mediated-HIF1α pathway. By exploring novel functions of B7-H3, our study fills a large knowledge gap in understanding the mechanisms underlying the role of B7-H3 in tumorigenesis and cancer progression, especially in understanding the underappreciated contribution of its non-immunological functions in B7-H3 mediated cancer pathology. The knowledge gained through carrying out the project will be paradigm shifting for B7-H3 biology and will be essential for developing efficient B7-H3 targeted therapy. Citation Format: Sangbin Lim, Hao Liu, Luciana Barnes, Ming Tan. The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1α. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 48.

The Oncoprotein Hbxip Promotes Glucose Metabolism Reprogramming Via Downregulating Sco2 And Pdha1 In Breast Cancer

The Oncoprotein HBXIP Suppresses Gluconeogenesis Through Modulating PCK1 to Enhance the Growth of Hepatoma Cells

The Oncoprotein Hbxip Enhances Angiogenesis And Growth Of Breast Cancer Through Modulating Fgf8 And Vegf

HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling

The Oncoprotein Hbxip Up-Regulates Skp2 Via Activating Transcription Factor E2f1 to Promote Proliferation of Breast Cancer Cells

The Oncoprotein HBXIP Upregulates Lin28B Via Activating TF II D to Promote Proliferation of Breast Cancer Cells.

The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells

The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis

The Oncoprotein HBXIP Promotes Human Breast Cancer Growth Through Down-Regulating P53 Via Mir-18B/mdm2 and Pakt/mdm2 Pathways

Hbxip Accelerates Glycolysis And Promotes Cancer Angiogenesis Via Akt/ Mtor Pathway In Bladder Cancer

Hepatitis B Virus X Protein Promotes Tumor Glycolysis by Downregulating Lncrna OIP5-AS1/HKDC1 in HCC

HBXIP Up-Regulates ACSL1 Through Activating Transcriptional Factor Sp1 in Breast Cancer

The Oncoprotein HBXIP Modulates the Feedback Loop of MDM2/p53 to Enhance the Growth of Breast Cancer

The Oncoprotein HBXIP Upregulates PDGFB Via Activating Transcription Factor Sp1 to Promote the Proliferation of Breast Cancer Cells

The Oncoprotein Hbxip Activates Transcriptional Coregulatory Protein Lmo4 Via Sp1 to Promote Proliferation of Breast Cancer Cells

Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer

The oncogenic role of HBXIP.

Oncoprotein HBXIP Induces PKM2 Via Transcription Factor E2F1 to Promote Cell Proliferation in ER-positive Breast Cancer

HBXIP Induces Anoikis Resistance by Forming a Reciprocal Feedback Loop with Nrf2 to Maintain Redox Homeostasis and Stabilize Prdx1 in Breast Cancer

Hepatitis B virus X protein differentially regulates the angiogenesis of Hepatocellular Carcinoma through p53-VEGF axis according to glucose levels

Abstract 48: the Immunoregulatory Protein B7-H3 Regulates Reprogramming of Cancer Cell Glucose Metabolism Through Reactive Oxygen Species Mediated Stabilization of HIF-1α